220 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
IONS Ionis Pharmaceuticals, Inc. $48.21 $6.62B N/A
Article Searches
Ionis Pharmaceuticals Inc (IONS) Files 10-K for the Fiscal Year Ended on December 31, 2018 http://www.gurufocus.com/news/826137/ionis-pharmaceuticals-inc-ions-files-10k-for-the-fiscal-year-ended-on-december-31-2018 Mar 01, 2019 - Ionis Pharmaceuticals Inc (IONS) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: IONS, release date:Mar 01, 2019
Ionis Pharmaceuticals (IONS) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/27/ionis-pharmaceuticals-ions-q4-2018-earnings-confer.aspx?source=iedfolrf0000001 Feb 27, 2019 - IONS earnings call for the period ending December 31, 2018.
Ionis Pharmaceuticals, Inc. (IONS) CEO Stan Crooke on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244953-ionis-pharmaceuticals-inc-ions-ceo-stan-crooke-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 27, 2019 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2018 Earnings Conference Call February 27, 2019 11:30 AM ET Company Participants Wade Walke - Vice President, Investor Relations Stan Crooke - Chairman of
Analysts Estimate Ionis Pharmaceuticals (IONS) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/355722/analysts-estimate-ionis-pharmaceuticals-ions-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-355722 Feb 20, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical Gets FDA Nod for Ion Endoluminal System http://www.zacks.com/stock/news/355677/intuitive-surgical-gets-fda-nod-for-ion-endoluminal-system?cid=CS-ZC-FT-355677 Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Earn 10.5% Yield To Maturity With Ion Geophysical's 2021 Bonds https://seekingalpha.com/article/4239976-earn-10_5-percent-yield-maturity-ion-geophysicals-2021-bonds?source=feed_all_articles Feb 11, 2019 - Ion Geophysical's earnings report sent the stock price higher and the bond price lower.The company's cash generation was impaired by increased receivables, which should help its 2019 performance.The t
ION Geophysical Corp. (IO) CEO Brian Hanson on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4239572-ion-geophysical-corp-io-ceo-brian-hanson-q4-2018-results-earnings-call-transcript?source=feed_all_articles Feb 08, 2019 - ION Geophysical Corp. (NYSE:IO) Q4 2018 Earnings Conference Call February 07, 2019 10:00 AM ET Company Participants Rachel White - VP, Corporate Communications Brian Hanson - President, Director and C
Has Ionis Pharmaceuticals (IONS) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/349996/has-ionis-pharmaceuticals-ions-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-349996 Jan 28, 2019 - Is (IONS) Outperforming Other Medical Stocks This Year?
Ironwood Commences Phase I Study on IW-6463 for CNS Disorders http://www.zacks.com/stock/news/349476/ironwood-commences-phase-i-study-on-iw-6463-for-cns-disorders?cid=CS-ZC-FT-349476 Jan 24, 2019 - Ironwood (IRWD) begins a phase I study on CNS-penetrant soluble guanylate cyclase stimulator, IW-6463, for treating severe CNS disorders.
4 Defensive Stocks to Buy Amid Shutdown and Brexit http://www.zacks.com/stock/news/347600/4-defensive-stocks-to-buy-amid-shutdown-and-brexit?cid=CS-ZC-FT-347600 Jan 16, 2019 - Defensive equities could ride out market unpredictability.

Pages: 12345678...22

<<<Page 3>